Short answer
Amgen (AMGN) filed its Q2 2025 10-Q quarterly report on Aug 6, 2025 for the quarter ended Jun 30, 2025. Quarterly revenue was $9.2B (up 9.4% year over year) with net income of $1.4B.
Q2 2025 key financials · XBRL
- Revenue
- $9.2B
- +9.4% YoY · +12.6% QoQ
- Net income
- $1.4B
- +92.0% YoY · −17.2% QoQ
- Operating margin
- 28.9%
- EPS (diluted)
- $2.64
- +91.3% YoY · −17.5% QoQ
Source: XBRL data from the Amgen (AMGN) Q2 2025 10-Q on SEC EDGAR. USD.
Amgen Q2 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- Financial risk: investment portfolio exposure to market fluctuations, impairments possible from interest rate hikes, inflation, and geopolitical events
- Financial risk: cash deposits exceed insured limits at multinational banks, risking delayed or inaccessible uninsured funds if institutions fail
- Market risk: volatility and disruption in global capital markets driven by COVID-19 and interest rates impacting access to capital on favorable terms
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Amgen quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.